Impact Advisory Board

The Impact Advisory Board (IAB) provides thought leadership and research expertise to guide Family Reach as we measure our impact on the financial burden of cancer. In order to provide comprehensive and meaningful services for patients and caregivers, Family Reach conducts ongoing measurement and evaluation of our services, including stakeholder surveys, literature reviews, intervention analyses, and focus groups. The Impact Advisory Board advises Family Reach on the strategy, design and delivery of these initiatives to ensure success in our data collection, analysis, and program improvements. The IAB also offers, contributes and reacts to new ideas that further enhance our mission of removing financial barriers to treatment in an equitable and accessible manner.


Peter C. Adamson, MD

Children’s Hospital of Philadelphia
Children’s Oncology Group
Blue Ribbon Panel, National Cancer Moonshot


Kira Bona, MD, MPH

Dana-Farber/Boston Children’s Cancer and Blood Disorders Center

Joe Chabot, MS

Dana-Farber/Boston Children’s Cancer & Blood Disorders Center


Lorraine T. Dean, ScD

Johns Hopkins Bloomberg School of Public Health

Elizabeth Franklin Headshot August 2020

Elizabeth Franklin, PhD, MSW



David Hong, MD

MD Anderson Cancer Center


Ryan Nipp, MD

Harvard Medical School
Massachusetts General Hospital


Scott Ramsey, MD

Fred Hutchinson Cancer Research Center
University of Washington Medical Center


Veena Shankaran, MD

Fred Hutchinson Cancer Research Center
University of Washington Medical Center
Seattle Cancer Care Alliance


Lillie D. Shockney, RN

John Hopkins Breast Center
Association of Oncology Nurse Navigators


Jonas de Souza, MD

Patient Access Network Foundation

Dr. Yousuf Zafar

Yousuf Zafar, MD

Duke Cancer Center